Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension

被引：0

作者：

Deodhar, Atul ^{[1
]}

van der Heijde, Desiree ^{[2
]}

Sieper, Joachim ^{[3
]}

Van den Bosch, Filip ^{[4
]}

Maksymowych, Walter ^{[5
]}

Kim, Tae-Hwan ^{[6
]}

Kishimoto, Mitsumasa ^{[7
]}

Ostor, Andrew ^{[8
]}

Combe, Bernard ^{[9
]}

Sui, Yunxia ^{[10
]}

Wang, Xin ^{[10
]}

Chu, Alvina D. ^{[10
]}

Song, In-Ho ^{[10
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] Charite Univ Med Berlin, Berlin, Germany

[4] Ghent Univ Hosp, Ghent, Belgium

[5] Univ Alberta, Edmonton, AB, Canada

[6] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea

[7] Kyorin Univ, Dept Nephrol & Rheumatol, Sch Med, Tokyo, Japan

[8] Monash Univ, Cabrini Med Ctr, Malvern, Vic, Australia

[9] Univ Montpellier, Montpellier, France

[10] AbbVie Inc, N Chicago, IL USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2023

引用

页数：4

共 50 条

[21] Switch of double-blind opicapone, entacapone or placebo to open-label opicapone: efficacy results of the 1-year extension of study BIPARK I
Ferreira, J.
Lees, A.
Tolosa, E.
Poewe, W.
Banach, M.
Santos, A.
Lopes, N.
Rocha, J. F.
Soares-Da-Silva, P.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 393 - 393
[22] Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
Baraliakos, Xenofon
Deodhar, Atul
Dougados, Maxime
Gensler, Lianne S.
Molto, Anna
Ramiro, Sofia
Kivitz, Alan J.
Poddubnyy, Denis
Oortgiesen, Marga
Vaux, Thomas
Fleurinck, Carmen
Shepherd-Smith, Julie
de la Loge, Christine
de Peyrecave, Natasha
van der Heijde, Desiree
ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1943 - 1958
[23] Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
van der Heijde, Desiree
Baraliakos, Xenofon
Sieper, Joachim
Deodhar, Atul
Inman, Robert D.
Kameda, Hideto
Zeng, Xiaofeng
Sui, Yunxia
Bu, Xianwei
Pangan, Aileen L.
Wung, Peter
Song, In-Ho
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11) : 1515 - 1523
[24] Efficacy and Tolerability of Elamipretide in Patients With Barth Syndrome: Results From Tazpower, a Randomized, Double-Blind, Placebo-Controlled, Crossover and Open-Label Extension Trial
Vernon, Hilary J.
Thompson, WIlliam R.
Aiudi, Anthony
Jones, John J.
Carr, Jim
Hornby, Brittany DeCroes
CIRCULATION, 2019, 140
[25] Results of the Open-Label Extension of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of AMG 334 for the Prevention of Episodic Migraine
Sun, Hong
Dodick, David W.
Goadsby, Peter
Silberstein, Stephen
Reuters, Uwe
Ashina, Messoud
Saper, Joel R.
Cady, Roger
Zhang, Feng
Trotman, Marie-Louise
Dietrich, Julie
Lenz, Robert
HEADACHE, 2015, 55 : 256 - 257
[26] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
Lesley M. Arnold
Kenneth N. Schikler
Lucinda Bateman
Tahira Khan
Lynne Pauer
Pritha Bhadra-Brown
Andrew Clair
Marci L. Chew
Joseph Scavone
Pediatric Rheumatology, 14
[27] SAFETY AND EFFICACY OF INCOBOTULINUMTOXINA FOR THE TREATMENT OF UPPER FACIAL LINES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY WITH OPEN-LABEL EXTENSION
Trevidic, Patrick
Connolly, Simon A.
Biwer, Bernard
Weissenberger, Petra
Kestemont, Philippe
Noah, Ernst M.
Sattler, Gerhard
Kerscher, Martina
TOXICON, 2018, 156 : S110 - S110
[28] Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
Arnold, Lesley M.
Schikler, Kenneth N.
Bateman, Lucinda
Khan, Tahira
Pauer, Lynne
Bhadra-Brown, Pritha
Clair, Andrew
Chew, Marci L.
Scavone, Joseph
PEDIATRIC RHEUMATOLOGY, 2016, 14
[29] Topiramate in migraine prophylaxis: An open-label extension of a double-blind, placebo-controlled study
Hart, DE
Calder, CS
Storey, JR
Riback, P
Potter, DL
Wymer, JP
Beesley, BA
NEUROLOGY, 2002, 58 (07) : A496 - A497
[30] Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia Results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial
Kato, Jitsu
Matsui, Norimitsu
Kakehi, Yoshihiro
Murayama, Emiko
Ohwada, Shoichi
MEDICINE, 2020, 99 (36) : E21976

← 1 2 3 4 5 →